TP53 hotspot mutations as immunoreactive neoantigens define a signature with differential survival outcomes in advanced ovarian cancer

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 30; pp. v417 - v418
Main Authors	Garziera, M., Cecchin, E., Polesel, J., Canzonieri, V., Sorio, R., Gagno, S., Scalone, S., Roncato, R., De Mattia, E., Poletto, E., Giorda, G.
Format	Journal Article
Language	English
Published	01.10.2019
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534
DOI:	10.1093/annonc/mdz250.030